Method Article

Bex-Plex Enables Simultaneous Visualization of Protein Markers and Ribonucleic Acid Transcripts for Deep Spatial Profiling of Intact Tissue

DOI:

10.3791/70303

July 3rd, 2026

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Here, we present a protocol for combining iterative protein staining (IBEX) with RNAscope in situ hybridization technology for the deep spatial phenotyping of intact fixed frozen tissues for high-resolution spatial profiling applications.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Here, we present a protocol to enable simultaneous spatial profiling of protein and ribonucleic acid (RNA) markers at single-cell resolution in intact tissues. One of the core issues surrounding solid tumor cancers is the inability to predict patient responsiveness to therapeutic intervention. Deciphering these complexities requires quantitative measurement of cellular behaviors, interactions, and phenotypes within intact tissues. Specifically, the proteome and transcriptome provide overlapping but nonredundant information that can be critical to designing rational immunotherapeutics. However, there is not currently a straightforward and cost-effective way to deeply profile both the transcriptional and functional state of all cells in the tumor microenvironment while retaining their critical spatial localization information. To this end, we have successfully combined the IBEX (iterative bleaching extends multiplexity) platform with HiPlex RNAscope to simultaneously visualize high-plex protein markers and high-plex ribonucleic acid (RNA) transcripts with single-cell resolution. This approach incorporates a modified RNA target retrieval step to preserve nuclear morphology and enable accurate image alignment across cycles. “Bex-Plex” enables us to perform an unmodified IBEX protocol on fixed frozen tissues followed by the HiPlex RNAscope protocol, in which we use a modified RNA target retrieval to ensure nuclear-level alignment with IBEX cycles. This protocol is optimized for fixed frozen tissues and enables integrated spatial analysis of transcriptional and functional cellular states. The power to profile at this single-cell level not only provides a deep well of information about the tissue itself but can also empower predictions about the nuanced cellular interactions that drive therapeutic responsiveness, providing a framework for studying spatial biology in tumor microenvironments and related systems.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Since their introduction in 2011, cancer immunotherapies that decrease the suppression of cytotoxic T cells by blocking inhibitory immune checkpoint molecules such as PDL-1 and CTLA-4 have emerged as the gold standard for solid tumor treatment1. However, despite large-scale use in patients, the clinical efficacies of these drugs vary widely because many solid tumor cancers either intrinsically present with or eventually generate resistance to these therapies2. In many cases this is due to the extremely heterogeneous nature of solid tumors, even among the same cancer type3. A more in depth understanding of the cell relationships that occur in solid tumors is key to generating improved treatment modalities. Thus, identifying the exact mechanisms and interactions that mount and sustain this resistance is at the forefront of cancer research. Here, we aim to develop a method that enables integrated spatial analysis of protein and RNA expression within intact tissues to better characterize these complex cellular interactions.

The tumor microenvironment (TME) is composed of the non-cancerous cellular and structural components that shape tumor growth and immune response, including cancer associated fibroblasts, infiltrating immune cells, vascular components, and the extracellular matrix4. Recently, it has become evident that the composition and organization of the TME strongly influence whether tumors are permissive or resistant to immune infiltration, one of the main factors dictating responsiveness to immunotherapy5. In many cancers, an “immune desert” phenotype, characterized by low numbers of T cells and the presence of highly immunosuppressive myeloid populations, correlates with poor responsiveness to checkpoint blockade therapies6,7. Chemokine signaling governs many of these recruitment dynamics. For example, CXCL1 and CCL2 attract immunosuppressive myeloid cells, while the CXCR3-CXCL9/CXCl10 axis recruits both cytotoxic and regulatory T cells into the tumor8. Consequently, the niche-specific signaling environment can potently influence cell phenotype and function. For instance, in colorectal cancer patients, the CCL5-CCR5 axis controls the suppressive function of tumor associated macrophages (TAMs) and blocking this signal skews TAM toward an anti-tumorigenic phenotype and correlates with improved clinical responses9. Furthermore, direct interactions between immune cells, cancer associated fibroblasts, and/or tumor cells via ICAM and PDL-1 can induce immune exhaustion and blunt antitumor immunity10. Together, these findings underscore the importance of spatially resolved analyses to understand how the TME influences therapeutic efficacy.

Immunofluorescent (IF) imaging remains a foundational approach for visualizing protein expression and cell-cell interactions in tissue. The field has advanced from conventional 3-4 color IF to high-content imaging workflows that rely on iterative staining and imaging. In these methods, large datasets are generated via repeated cycles of antibody labeling, imaging, and fluorophore inactivation or removal so that additional markers can be stained and imaged11. Iterative Bleaching Extends Multiplexity (IBEX) was recently introduced as a user-friendly and cost-effective iterative imaging platform12. Compatible with the use of commercial antibodies and conventional microscopes, IBEX utilizes lithium borohydride (LiBH4) to quench the fluorescence of most commonly used dyes without damaging tissue epitopes, allowing for the acquisition of up to 75 parameters for a single tissue13. The images obtained from this cyclic staining are aligned using the SimpleITK open-source software to produce composite datasets suitable for high-dimensional spatial analyses.

Complementary to protein-level phenotyping, spatial transcriptomic methods can provide valuable information about the transcriptional state of cells within their native environment. Notably, in-situ hybridization (ISH) is a popular technique to identify the localization of DNA or RNA sequences in a specific tissue11. RNAscope is a well-established ISH approach that uses probes with a unique Z chemistry to specifically amplify RNA transcripts at single-molecule resolution and is compatible with many different sample types14. As a widely adopted and commercially available platform through Advanced Cell Diagnostics (ACD), RNAscope offers validated probes against a wide variety of targets, simplifying experimental design for diverse applications.

A more complete view of cell identity and functions can be gained by combining protein and RNA detection within the same tissue. Short-lived secreted proteins, such as cytokines and chemokines, traditionally lack reliable antibody staining by IHC, but information about their expression can be gained through the quantification of their mRNA transcripts. Previous attempts to co-detect RNA and protein, such as conventional chromogenic IHC or TSA-OPAL, have been limited by nonlinear signal amplification and time- consuming antigen retrieval protocols15. Compared to these approaches, the Bex-Plex method enables simultaneous high-plex protein and RNA detection while preserving spatial context and nuclear morphology for accurate image registration.

Here we present “Bex-Plex”, a protocol that integrates the IBEX and RNAscope platforms for simultaneous, quantifiable characterization of the transcriptional and translational states of cells within their native tissues. In Bex-Plex, fixed OCT embedded tissues undergo the standard IBEX protocol followed by a slightly modified RNAscope HiPlex workflow, wherein target retrieval is performed at 60°C with a 1 h incubation time as compared to the original 99°C incubation for 5 min. This preserves the architecture of the nuclei, allowing for an accurate alignment of fiducial markers when registering the separate images from the IF and ISH cycles into one. This protocol is best suited for studies requiring simultaneous spatial analysis of protein and RNA expression in intact tissues, particularly when tissue availability is limited or when preserving spatial architecture is critical, such as in tumor microenvironment analysis or immune profiling studies.

Using widely available reagents and compatible with most imaging platforms, Bex-Plex can be carried out by any technically trained research personnel familiar with fluorescent imaging and with access to a conventional microscope. The protocol presented here is optimized for fixed frozen samples. At present, the protocol has been validated in fixed frozen tissues, and further optimization may be required for application to other sample types such as FFPE or human clinical specimens.

This workflow will be invaluable for any context where tissue is limited or precious, such as tissue biopsies or animal experiments that have a limited sample size, as well as for the phenotyping of cells that may be difficult to extract using dissociative techniques. Bex-Plex provides simultaneous, quantifiable information about the transcriptional and translational profiles of single cells while retaining their spatial context, data that is uniquely poised to answer questions about the relationships and crosstalk between cells in their original environment.

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The procedures outlined in this protocol were approved by the Institutional Animal Care and Use Committee of the University of California, San Diego (protocol number S24049). Male and female mice 7-12 weeks of age on a C57BL/6 genetic background and housed under specific pathogen-free conditions were used for these experiments.

1. Tissue preparation

  1. Euthanize experimental mice by approved primary and secondary measures (e.g. CO2 euthanasia and cervical dislocation) and harvest tissues of interest into supplemented media.  
  2. Prepare a fresh stock of tissue fixative by diluting a 4% stock solution of paraformaldehyde (PFA) to either 0.5% or 1% PFA in 1X PBS. Use 0.5% PFA for lower-volume tissues such as lymph nodes and 1% PFA for higher-volume tissues such as tumors..   
    CAUTION: Paraformaldehyde is flammable and toxic if ingested or swallowed. Handle with proper PPE and avoid contact with skin or eyes.
  3. Transfer tissues into a 24 well plate with 2 mL fixative per well and incubate overnight at 4°C.
    Note: Incubation times over 16 h can lead to over-fixation issues.
  4. Fill the wells of a new 24-well plate with 1X PBS and transfer tissues over from the fixative plate.
    Pause point: If needed, tissues can be stored in 1X PBS at 4°C for up to 7 days.
  5. Trim excess fat/debris from the tissues one at a time using a dissection scope and tools. Add a small volume of 1X PBS directly to the tissue to prevent tissue dehydration while trimming.
  6. Prepare a 30% w/v sucrose solution by diluting powdered sucrose stock in 1X PBS.
  7. Transfer the tissues into a 24 well plate with 2 mL 30% sucrose per well and incubate overnight at 4°C to dehydrate. The tissues are adequately dehydrated when they sink to the bottom of the wells.
  8. Fill labeled cryomolds with OCT and place the tissues one at a time into the molds. Tissue orientation will be origin dependent, but our standard recommendation would be for the largest surface area to be parallel with the cryomold bottom. Ensure the tissues are completely submerged in the OCT.
  9. Place on dry ice for 10 min to freeze and store at -80°C.

2. Tissue sectioning

Note: All reagents and lab materials used for this protocol must be RNase free. Take care to prevent contamination when handling slides.

  1. Coat RNase free microscope slides with 15 µL of chrome alum adhesive and incubate for 1 h at 60°C in an oven. Chrome alum coated slides can be stored at RT (room temperature) for up to a month before use.
  2. Take the OCT embedded tissues out of the -80°C freezer and place in a -20°C cryostat/cryotome to equilibrate for at least 20 min.
  3. Section tissues onto chrome alum coated slides at a thickness of 10–15 µm.
  4. Store slides with cut sections at 4°C or, if staining the same day, let slides equilibrate to RT. Sectioned slides can be stored at 4°C for up to 5 days before use.

3. Protein staining

  1. In a dunk tank, soak the slide to be stained in RNase-free 1X PBS for 5 min to remove excess OCT from the tissues.
  2. Use a hydrophobic barrier pen to draw boxes around the tissues on the slide and let dry for 2 min.
  3. Prepare a blocking solution of 10 µg·mL⁻1 anti-mouse FC receptor block in RNase-free 1X PBS. Add the blocking buffer to the samples on the slide, using enough to create a bubble that completely covers the tissue (100–150 µL·section-1).
    Note: Sometimes the addition of FBS or BSA (typically 1–2%) to the blocking buffer is required for difficult tissues and/or markers.
  4. Incubate the slides at RT in a humid staining box for 1 h, then wash by completely submerging them in a dunk tank filled with RNase-free 1X PBS for 5 min. 
  5. Prepare the primary antibody staining solution in RNase-free 1X PBS, planning for 100-200 µL per tissue section. Standard antibody dilutions range from 1:50-1:200, but it is advised to perform single stain titrations to identify the best dilution factor for a particular antibody and/or tissue type. Vortex and pulse spin the antibodies before pipetting to prevent fluorescent aggregates.
  6. Remove slides from the wash and gently wick the excess liquid from the corner of sample boxes using an absorbent task wipe to avoid diluting the antibody solution. 
  7. Apply the antibody solution in the same manner as the blocking solution, making a bubble over the tissue.  
  8. Place slides horizontally in a 37°C oven and incubate for 1 h. Alternatively, Incubate slides at RT for 3–4 h in a humid box. Standard IF protocols already optimized for the desired tissue of interest may be used. Maintain slides in a humid environment during incubation to prevent dehydration. (e.g. use a wet paper towel in the bottom of the staining tray).
  9. Wash the slides by submerging in RNase-free 1X PBS for 2 min. Repeat twice for a total of three washes. If necessary for your staining panel, prepare a secondary antibody staining solution in RNase-free 1X PBS during this time. Standard antibody dilutions range from 1:500-1:1000, but it is advised to perform single stain titrations to identify the best dilution factor for a particular antibody and/or tissue type.
  10. Wick any excess PBS off the slides with an absorbent task wipe and add 100–200 µL of secondary antibody staining solution to each tissue section. Place slides horizontally in a 37°C in an oven and incubate for 30 min. Alternatively, slides may be stained at RT for 1–2 h in a humid box.
  11. Wash the slides by submerging in 1X RNase-free PBS for 2 min. Repeat twice for a total of three washes.
  12. Dilute DAPI nuclear dye to a final concentration of 0.2 µg·mL⁻1 in RNase-free 1X PBS.and add 100–200 µL to each tissue section.
  13. Incubate slides for 10 min at RT in a humid box, then wash once by submerging in RNase-free 1X PBS and dunking up and down briefly.
  14. Wick the excess liquid off the slides with an absorbent task wipe and add 20–30 µL of aqueous-base antifade mounting medium to each section. Carefully place a coverslip on the slide, making sure to minimize any bubbles, and let the mounting medium cure for 15–30 min.
  15. Image the stained slides. For a more detailed explanation of panel design considerations and image acquisition for IBEX, see the original published IBEX protocols12,13.
    Pause point: Store mounted slides in the dark at 4°C for up to 3 days, though we recommend proceeding immediately to ensure minimal RNA degradation.

4. Fluorophore bleaching and iterative protein staining

  1. Submerge the slides in RNase-free 1X PBS until the cover slip easily slides off without any application of force. Depending on how long the coverslip has been mounted this can take up to 16 h.
  2. While the slides are soaking, Prepare a 1 mg·mL⁻1 solution of LiBH₄ in RNase-free DI H₂O by gently mixing until fully dissolved and wait 10 min for it to activate. Activation has occurred when bubbles are present in the solution and activity lasts for up to 4 h.
    Caution: LiBH4 is water reactive, avoid excess exposure of powdered stock to moisture and properly dispose of waste accordingly.
  3. Wash the slides once for 2 min in RNase-free 1X PBS to remove any mounting medium residue, then pipette 100–150 µL of the LiBH4 solution onto each tissue. Incubate in a humid box for 15 min.
    Note: Depending on the fluorophores used for staining, this incubation time may need to be lengthened (discussed at length in the IBEX methods papers)12,13.
  4. Wash the slides once by submerging in RNase-free 1X PBS and dunking up and down briefly.
  5. Proceed to staining the slides with additional protein markers by following steps 3.5-3.15. It is not necessary to re-stain the nuclear dye because it does not bleach with LiBH4. Repeat protein staining if necessary.
    Pause point: Mounted slides may be stored at 4°C overnight before bleaching the last protein/IBEX cycle and proceeding to RNA.
  6. Immediately proceed to RNAscope HiPlex after bleaching the fluorophores from the final cycle. Although up to six cycles of standard IBEX have been performed without tissue or epitope loss, we do not recommend exceeding three cycles of protein staining for this protocol due to the potential for RNA transcript quality to decrease over longer periods of time.

5. Slide preparation for RNAscope HiPlex

  1. Submerge the slides completely in RNase-free 1X PBS until the coverslip easily slides off without any application of force. Depending on how long the coverslip has been mounted this can take up to 16 h. Wash once for 2 min in RNase-free 1X PBS to remove any mounting medium residue.
  2. Prepare 200 mL of 50% ethanol, 200 mL of 70% ethanol, and 400 mL of 100% ethanol.
  3. Turn on a hybridization oven and set it to 60°C. Dilute the 10X Target Retrieval Reagent to a 1X working stock in RNase-free DI H2O and prewarm by placing it in the oven until step 5.8.
    Note: Failure to pre-warm target retrieval reagent to 60°C will affect downstream registration of images from the separate cycles. The target retrieval reagent must remain at 60°C for the duration of the retrieval step.
  4. Immerse the slides in 50% ethanol. Incubate for 5 min at RT.
  5. emove the slides from the 50% ethanol and immerse in 70% ethanol. Incubate for 5 min at RT.
  6. Remove the slides from the 70% ethanol and immerse in 100% ethanol. Incubate for 5 min at RT and repeat with fresh 100% ethanol.
  7. Remove the slides from the 100% ethanol and let dry at RT for 5 min.
  8. Add 100–150 µL of the 60°C 1X Target Retrieval Reagent to each tissue section and place the slides in the hybridization oven. Incubate at 60°C for 1 h.
  9. Remove the slides and rinse by submerging in RNase-free DI H2O for 15 seconds. At this time, change the set temperature on the oven to 40°C.
  10. Transfer the slides to 100% ethanol and incubate for 5 min, then dry at RT for a minimum of 5 min.
  11. Apply Protease III to the slides, 1–2 drops per tissue section. Place the slides in the hybridization oven and incubate at 40°C for 30 min.
  12. Submerge the slides in RNase-free DI H2O and wash by dunking up and down briefly. Repeat with fresh distilled water for a total of 2 washes.

6. RNAscope reagent preparation and probe hybridization

  1. Prepare the RNAscope HiPlex probe stocks and HiPlex probe diluent by warming them to 40°C for 10 min in an oven or water bath.
  2. Briefly pulse spin down all 50X probe stocks. Prepare a working probe mixture by diluting each unique target probe to 1X with the RNAscope Probe Diluent. Plan to use 50–100 µL of probe mixture per tissue and mix it well by vortexing before use. The RNAscope HiPlex protocol can accommodate up to 3 cycles of 4 probes (12 probes total that are denoted T1-12). For guidance on probe design, consult the original published RNAscope protocol14.
  3. Place the RNAscope HiPlex Amp 1–3 and HiPlex Fluoro T1-T4 reagents at RT to equilibrate.
  4. Take the Protease III treated slides and pipette 50–100 µL of the probe mixture onto each tissue section. Place horizontally into the hybridization oven and incubate for 2 h at 40°C.
  5. Wash the slides by completely submerging in 1X Wash buffer for 2 min. Repeat with fresh buffer for a total of 2 washes.
    Pause point: Slides may be stored in 5X SSC buffer at RT overnight, as described in the RNAscope protocol from ACD. If this pause point is used, note that two 2 min washes in 1X wash buffer will be required the following morning.

7. Probe amplification

Note: Ensure that all reagents are equilibrated to RT before applying to slides.

  1. Add 1–2 drops of the HiPlex Amp1 reagent to the slides and incubate in the hybridization oven at 40°C for 30 min. Wash the slides by submerging completely in 1X Wash buffer for 2 min. Repeat for a total of 2 washes.
  2. Add 1–2 drops of the HiPlex Amp2 reagent to the slides and incubate in the hybridization oven at 40°C for 30 min. Wash the slides by submerging completely in 1X Wash buffer for 2 min. Repeat for a total of 2 washes.
  3. Add 1–2 drops of the HiPlex Amp3 reagent to the slides and incubate in the hybridization oven at 40°C for 30 min. Wash the slides by submerging completely in 1X Wash buffer for 2 min. Repeat for a total of 2 washes.
  4. Add 1–2 drops of the HiPlex Fluoro T1-T4 reagent to the slides and incubate in the hybridization oven at 40°C for 15 min. Wash the slides by submerging completely in 1X Wash buffer for 2 min. Repeat for a total of 2 washes.
  5. Add 3–4 drops of HiPlex DAPI reagent to each tissue section and incubate for 1 min at RT.
  6. Remove the DAPI by wicking the liquid off the slides with an absorbent task wipe. Immediately add 100 µL of aqueous-base antifade mounting medium (can be the same as used during the IBEX staining steps) to each section. Carefully place a coverslip on the slide, making sure to minimize bubbles, and let the mounting medium dry for 15–30 min.
  7. Proceed to imaging.
    Pause point: Mounted slides may be stored in the dark at 4°C for up to 3 days, though we recommend proceeding quickly to ensure minimal RNA degradation.

8. Cleaving the fluorophores and iterative RNA hybridization

  1. To remove the cover slips from the slides, soak in 4X SSC buffer for at least 30 min at RT. Wash once by completely submerging the slides in fresh 4X SSC buffer and dunking up and down briefly.
  2. Open a fresh ampule of cleaving solution and make a 10% working stock by diluting with 4X SSC buffer.
  3. Place the slides in a humid box and add 3–4 drops of the 10% cleaving solution. Incubate at RT for 15 min, then wash the slides by completely submerging in 0.5% PBST for 2 min. Repeat with fresh PBST for a total of 2 washes.
  4. To proceed with imaging cycle 2 of the RNAscope panel, equilibrate the HiPlex Fluoro T5-T8 reagent to RT.
  5. Turn on the hybridization oven and set the temperature to 40°C.
  6. Add the HiPlex Fluoro T5-T8 reagent to the slides and incubate in the hybridization oven at 40°C for 15 min. Wash the slides by submerging completely in 1X Wash buffer for 2 min. Repeat for a total of 2 washes.
  7. Carefully wick the excess liquid from the slides. Immediately add 100 µL of mounting medium to each section and carefully place a coverslip on the slide. Let the mounting medium dry for 15–30 min and proceed to imaging.
  8. Repeat steps 8.1–8.7 with the HiPlex Fluoro T9-T12 reagent for a total of 3 RNAscope cycles if appropriate. Note that while 3 cycles are possible with the RNAscope HiPlex protocol, the additional time required for protein staining with this protocol may affect RNA quality. Therefore, 3 cycles may not always be feasible depending on the specific transcripts being targeted.

9. Image processing

  1. Individually process the raw files from each round and Perform image processing using consistent parameters, including background subtraction settings, smoothing filters, and registration transformation type.. Channels should be named with a consistent separator character (e.g. Cycle 1: CD45 AF532, where “:” makes the distinction between cycle and marker/fluor).
  2. Launch the SimpleITK software (https://github.com/niaid/sitk-ibex) and click Imaris extensions > SimpleITK > Affine registration of z-stack using common channel.
  3. Upload one image file from each of the multiplex cycles and enter the separator character for all named channels (e.g. “:”).
  4. Select the channel to be used for image registration and the fixed image that all other images will be aligned to. It is recommended to use DAPI as the fiducial marker although any common named channel between all cycles can be used.
  5. Click “Register” and then “Resample and save combined image”.
  6. Proceed to downstream analysis with your software of choice. For more information on image processing and registration, reference the original IBEX protocol12,13.

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Protein staining process diagram; includes fluorophore bleach, RNA hybridization, image registration.
Figure 1 : Overview of Bex-Plex workflow.
Fixed frozen tissues sectioned onto chrome alum-coated slides undergo up to 3 cycles of standard IBEX followed by up to three cycles of RNAScope HiPlex wherein the initial target retrieval step is performed at 60°C for 1 h. Images ...

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The Bex-Plex workflow integrates the iterative protein staining platform, IBEX, with RNAscope in situ hybridization to enable simultaneous detection of proteins and RNA transcripts at single-cell resolution. The primary goal of this protocol is to provide a reproducible method for integrated spatial analysis of protein and RNA expression within intact tissues. The ability to measure both protein and RNA expression in the same tissue has previously presented technical challenges: high costs, complex antigen retri...

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors declare no competing financial interests. No AI-based tools were used in the preparation of this manuscript.

Author contributions:

SK contributed to data curation, data analysis, investigation, and writing. CM contributed to data curation. PH contributed to data analysis. AV contributed to data curation. VM contributed to conceptualization, data curation, data analysis, supervision, and writing.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This work was supported by the University of California San Diego Department of Pediatrics, Division of Allergy, Immunology, and Rheumatology and NIH NIGMS grant R00GM147841 (MOSAIC K99/R00) and NCI U54CA272220 (UC San Diego FIRST grant). The authors would additionally like to thank Andrea Radtke for establishing the original IBEX method, without which we would have been unable to create Bex-Plex.

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
1.5 ml microcentrifuge tubesBiopioneerMCNT-1.5F
200 proof EtOHFisher ScientificBP28184
20X SSC bufferInvitrogenAM9765
24 well plates
Alexa Fluor 488 anti-mouse CD11b AntibodyBiolegend101217
Alexa Fluor 523 anti-mouse CD3e AntibodyInvitrogen58-0032-82
Alexa Fluor 647 anti-mouse Ly6G AntibodyBiolegend127610
Alexa Fluor 700 anti-mouse CD68 AntibodyBiolegend137025
BD Cytofix/Cytoperm fixation and permeablization solutionBD554722
Chrome alum gelatinFisherNC1692262
Confocal microscope (e.g Leica Stellaris)
CryomoldsVWR25608-922
Cryostat (e.g CryoStar NX50 Cryostat)Thermofisher Scientific957100
Cryostat blades (e.g Leica Low Profile Disposable Blades DB80LX)Leica Biosystems14035843496
DAPIThermofisher Scientific62248
Dissection microscope (e.g Zeiss SteREO Discovery.V8)
Dissection tools
Dry Ice
Dunk tank for slide staining (e.g Simport Scientific EasyDip Slide Staining Jars)Fisher Scientific 22-038-489
Fluoromount-GFisherOB10001
Heated water bath
Histology brushes (e.g. Ted Pella Camel Hair Brushes)Fisher ScientificNC2023341
Hybridization oven (e.g. HybEZ II Hybridization System)ACD321710
Image analysis software of choice
ImmEdge Hydrophobic Barrier PAP PenVector LaboratoriesH-4000
Kimwipes VWR21905-026
Lithium borohydrideSTREM Chemicals93-0397
Micropipettes (P-10, P-20, P-200, P-1000)
Mini Microcentrifuge (e.g. Corning LSE Mini Microcentrifuge)Corning6770
Mouse BD Fc BlockBD553142
No 1.5 CoverglassVWR48393-241
Pipette tips (P-10, P-20, P-200, P-1000)
RNAscope HiPlex Probe, mm-CD274-T7ACD420501-T7
RNAscope HiPlex Probe, mm-IL-10-T6ACD317261-T6
RNAscope HiPlex12 Reagents Kit v2 (includes detection kit, cleaving stock solution, protease reagents, target retreival reagents, and wash buffer)ACD324409
RNAscope Protease IIIACD322337
RNase ZAPMillipore SigmaR2020-250
Simple ITK software: https://github.com/niaid/sitk-ibex
Slide staining tray/humidity chamber
Sucrose BioxtraSigmaS7903-1KG
Superfrost Plus Microscope slidesVWR48311-703
Tissue-Tek OCTVWR25608-930
Tween-20, Molecular Biology gradePromegaH5152
UltraPure DNase/RNase free waterFisher Scientific10977023

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Ribas, A., Wolchok, J. D. Cancer immunotherapy using checkpoint blockade. Science. 359 (6382), 1350-1355 (2018).
  2. Zhao, X., Subramanian, S. Intrinsic resistance of solid tumors to immune checkpoint blockade therapy. Cancer Res. 77 (4), 817-822 (2017).
  3. Bailey, P., et al. Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma. Sci Rep. 6 (35848), (2016).
  4. Belli, A., et al. Targeting the microenvironment in solid tumors. Canc Treat Rev. 65 (1), 22-32 (2018).
  5. Fridman, W. H., Zitvogel, L., Sautès–Fridman, C., Kroemer, G. The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol. 14 (1), 717-734 (2017).
  6. Bonaventura, P., et al. Cold tumors: A therapeutic challenge for immunotherapy. Front Immunol. 10 (168), (2019).
  7. Li, J., et al. Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy. Immunity. 49 (1), 178-193 (2018).
  8. Tokunaga, R., et al. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer Treat Rev. 63 (1), 40-47 (2018).
  9. Halama, N., et al. Tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by anti-CCR5 therapy in cancer patients. Cancer Cell. 29 (1), 587-601 (2016).
  10. Kawasaki, K., et al. PD-L1-expressing cancer-associated fibroblasts induce tumor immunosuppression and contribute to poor clinical outcome in esophageal cancer. Cancer Immunol Immunother. 72 (11), 3787-3802 (2023).
  11. Lee, C. Y. C., McCaffrey, J., McGovern, D., Clatworthy, M. R. Profiling immune cell tissue niches in the spatial -omics era. J allergy Clin Immunol. 155 (3), 663-677 (2025).
  12. Radtke, A. J., et al. IBEX: an iterative immunolabeling and chemical bleaching method for high-content imaging of diverse tissues. Nat Protoc. 17 (1), 378-401 (2022).
  13. Radtke, A. J., et al. IBEX: A versatile multiplex optical imaging approach for deep phenotyping and spatial analysis of cells in complex tissues. Proc Natl Acad Sci U.S.A. 117 (52), 33455-33465 (2020).
  14. Wang, F., et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn. 14 (1), 22-29 (2012).
  15. Stack, E. C., Wang, C., Roman, K. A., Hoyt, C. C. Multiplexed immunohistochemistry, imaging, and quantitation: A review, with an assessment of tyramide signal amplification, multispectral imaging and multiplex analysis. Methods. 70 (1), 46-58 (2014).
  16. Maltez, V. I., et al. Agonistic anti-CD40 antibody treatment converts resident regulatory T cells into activated type 1 effectors within the tumor microenvironment. Immunity. , (2026).
  17. Ben-Chetrit, N., et al. Integration of whole transcriptome spatial profiling with protein markers. Nat Biotechnol. 41, 788-793 (2023).
  18. Grabinski, T. M., Kneynsberg, A., Manfredsson, F. P., Kanaan, N. M. A method for combining RNAscope in situ hybridization with immunohistochemistry in thick free-floating brain sections and primary neuronal cultures. PLoS ONE. 10 (3), e0120120(2015).
  19. Dikshit, A., Zong, H., Anderson, C., Zhang, B., Ma, X. J. Simultaneous visualization of RNA and protein expression in tissue using a combined RNAscope in situ hybridization and immunofluorescence protocol. Methods Mol Biol. 2148, 301-312 (2025).
  20. Radtke, A. J., et al. The IBEX knowledge-base: A central resource for multiplexed imaging techniques. PLoS Biol. 23 (3), e3003070(2025).

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Cancer ResearchAllIBEXCancerImagingTumor MicroenvironmentSpatial Transcriptomics
Video Coming Soon

Related Articles